-
Product Name
BCCIP antibody
- Documents
-
Description
BCCIP Rabbit Polyclonal antibody. Positive WB detected in HeLa cells, A549 cells. Positive IP detected in HeLa cells. Positive IF detected in HeLa cells. Observed molecular weight by Western-blot: 50-58 kDa
-
Tested applications
ELISA, WB, IP, IF
-
Species reactivity
Human,Mouse,Rat; other species not tested.
-
Alternative names
BCCIP antibody; Protein TOK 1 antibody; TOK 1 antibody; TOK1 antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of BCCIP recombinant protein (Accession Number: NM_078468). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:200-1:2000
IP: 1:200-1:2000
IF: 1:50-1:500
-
Validations
HeLa cells were subjected to SDS PAGE followed by western blot with Catalog No:108384(BCCIP antibody) at dilution of 1:800
IP Result of anti-BCCIP (IP:Catalog No:108384, 4ug; Detection:Catalog No:108384 1:800) with HeLa cells lysate 3200ug.
Immunofluorescent analysis of (10% Formaldehyde) fixed HeLa cells using Catalog No:108384(BCCIP Antibody) at dilution of 1:50 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)
-
Background
BCCIP (or TOK1) is isolated as a BRCA2- and CDKN1A (p21)-interacting protein and is implicated in homologous recombination (HR) pathway and inhibition of DNA replication stress. BCCIP is an evolutionarily conserved nuclear protein with multiple interacting domains. BCCIP deficiency in mice impaired embryonic and postnatal neural development, causing severe ataxia, cerebral and cerebellar defects, and microcephaly, which are associated with spontaneous DNA damage and subsequent cell death in the proliferative cell populations of the neural system during embryogenesis. BCCIP is essential for maintaining the transactivation activity of wild type p53 suggesting a potential role of BCCIP in cancer etiology.
-
References
- Liu X, Cao L, Ni J. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues. International journal of oncology. 43(6):1925-34. 2013.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"